Cited by 5,141Research on Leishmaniasis StudiesLeprosy Research and TreatmentBrucella: diagnosis, epidemiology, treatment

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Open access

Alvar, Jorge, Vélez, Iván D., Bern, Caryn, Herrero, Mercé, Desjeux, Philippe, Cano, Jorge, Jannin, Jean, Boer, Margriet den, the WHO Leishmaniasis Control Team·2012·PLoS ONE

DOI 10.1371/journal.pone.0035671PMC PMC3365071

Open this paper in CoChat — free account Open PDF

Abstract

As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035671

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
Background
World Development Report 1993
Bank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
Background
Health metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
Background
Leishmaniasis and poverty
Alvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
Background
Leishmaniasis
Desjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
Background
Control Of The Leishmaniases
Library, W. (2010) · Cited by 584

Show all 51 references

Research works printed but not linked: 1

AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931

Sorted by citations

Items 901–1,000 of 1,004

Value of the oral swab for the molecular diagnosis of dogs in different stages of infection with Leishmania infantum
Ferraz, M. A., de Oliveira, E. T. B., Laurenti, M. D., Marcondes, M., Tolezano, J. E., Hiramoto, R. M., Corbett, C. E. P., & da Matta, V. L. R. (2016) · Veterinary Parasitology · doi:10.1016/j.vetpar.2016.06.005 · Cited by 38
Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
Tamiru, A., Tigabu, B., Yifru, S., Diro, E., & Hailu, A. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1746-1 · Cited by 38
Predicting death from kala-azar: construction, development, and validation of a score set and accompanying software
Costa, D. L., Rocha, R. L., Chaves, E. D. B. F., Batista, V. G. D. V., Costa, H. L., & Costa, C. H. N. (2016) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0258-2016 · Cited by 38
Leishmania in synanthropic rodents (Rattus rattus): new evidence for the urbanization of Leishmania (Leishmania) amazonensis
Caldart, E. T., Freire, R. L., Ferreira, F. P., Ruffolo, B. B., Sbeghen, M. R., Mareze, M., Garcia, J. L., Mitsuka‐Breganó, R., & Navarro, I. T. (2017) · Revista Brasileira de Parasitologia Veterinária/Brazilian Journal of Veterinary Parasitology · doi:10.1590/s1984-29612017001 · Cited by 38
Thiadiazoles: the appropriate pharmacological scaffolds with leishmanicidal and antimalarial activities: a review.
Tahghighi, A., & Babalouei, F. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8828 · Cited by 38
A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
Taslimi, Y., Sadeghipour, P., Habibzadeh, S., Mashayekhi, V., Mortazavi, H., Müller, I., Lane, M. E., Kropf, P., & Rafati, S. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005750 · Cited by 38
Cutaneous leishmaniasis in northwestern Saudi Arabia: identification of sand fly fauna and parasites
Haouas, N., Amer, O., Alshammrie, F. F., Shorooq, A.-S., Remadi, L., & Ashankyty, I. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2497-6 · Cited by 38
Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis
Wijnant, G.-J., Bocxlaer, K. V., Yardley, V., Harris, A., Murdan, S., & Croft, S. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02009-17 · Cited by 38
Visceral and Cutaneous Leishmaniasis Recommendations for Solid Organ Transplant Recipients and Donors
Clemente, W. T., Mourão, P. H. O., López‐Medrano, F., Schwartz, B. S., García‐Donoso, C., & Torre‐Cisneros, J. (2018) · Transplantation · doi:10.1097/tp.0000000000002018 · Cited by 38
A new chimeric triple reporter fusion protein as a tool for in vitro and in vivo multimodal imaging to monitor the development of African trypanosomes and Leishmania parasites
Alvarez, E. C., Travaillé, C., Crouzols, A., & Rotureau, B. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.01.011 · Cited by 38
In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis
de Macedo-Silva, S. T., Visbal, G., Godinho, J. L. P., Urbina, J. A., de Souza, W., & Rodrigues, J. C. F. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky229 · Cited by 38
Genetic diversity, phylogeography and molecular clock of the Lutzomyia longipalpis complex (Diptera: Psychodidae)
Pech‐May, A., Ramsey, J. M., González‐Ittig, R. E., Giuliani, M. G., Berrozpe, P., Quintana, M. G., & Salomón, O. D. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006614 · Cited by 38
Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India
Bulstra, C. A., Rutte, E. A. L., Malaviya, P., Hasker, E. C., Coffeng, L. E., Picado, A., Singh, O. P., Boelaert, M., de Vlas, S. J., & Sundar, S. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006888 · Cited by 38
Effectiveness of deltamethrin-impregnated dog collars on the incidence of canine infection by Leishmania infantum: A large scale intervention study in an endemic area in Brazil
Coura‐Vital, W., Leal, G. G. D. A., Marques, L. A., Pinheiro, A. D. C., Carneiro, M., & Reis, A. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208613 · Cited by 38
Efficacy of manganese oxide (Mn2O3) nanoparticles against Leishmania major in vitro and in vivo
Tavakoli, P., Ghaffarifar, F., Hamid Delavari, H., & Shahpari, N. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.08.003 · Cited by 38
Potential use of 13-mer peptides based on phospholipase and oligoarginine as leishmanicidal agents
Mendes, B. D. S., Almeida, J. R., Vale, N., Gomes, P. A. C., Gadelha, F. R., Silva, S. L. D., & Miguel, D. C. (2019) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2019.108612 · Cited by 38
Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis
Kawakami, M. Y. M., Zamora, L. O., Araújo, R. S., Fernandes, C. P., Ricotta, T. Q. N., Oliveira, L. G., Queiroz‐Junior, C. M., Fernandes, A. P., da Conceição, E. C., Ferreira, L. A. M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111109 · Cited by 38
Endogenous Enzymatic Antioxidant Defense and Pathologies
Eddaikra, A., & Eddaikra, N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95504 · Cited by 38
The Heme Transport Capacity of LHR1 Determines the Extent of Virulence in Leishmania amazonensis
Renberg, R. L., Yuan, X., Samuel, T. K., Miguel, D. C., Hamza, I., Andrews, N. W., & Flannery, A. R. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003804 · Cited by 36
Leishmanicidal Effect of Synthetic trans-Resveratrol Analogs
Passos, C. L. A., Ferreira, C., Soares, D. C., & Saraiva, E. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141778 · Cited by 38
In vitro antileishmanial activity of Mexican medicinal plants
Delgado‐Altamirano, R., Monzote, L., Piñón, A., Vibrans, H., Rivero-Cruz, J. F., Ibarra‐Alvarado, C., & Rojas‐Molina, A. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00394 · Cited by 38
Different Host Complement Systems and Their Interactions with Saliva from Lutzomyia longipalpis (Diptera, Psychodidae) and Leishmania infantum Promastigotes
Mendes‐Sousa, A. F., Nascimento, A. A. S., Queiroz, D. C., do Vale, V. F., Fujiwara, R. T., Araújo, R. N., Pereira, M. H., & Gontijo, N. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079787 · Cited by 37
Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia
Endris, M., Takele, Y., Woldeyohannes, D., Tiruneh, M., Mohammed, R., Moges, F., Lynen, L., Jacobs, J. A., van Griensven, J., & Diro, E. (2014) · BioMed Research International · doi:10.1155/2014/361058 · Cited by 37
Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?
Kamhawi, S., Aslan, H., & Valenzuela, J. G. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00099 · Cited by 37
Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene
Reimão, J. Q., Miguel, D. C., Taniwaki, N. N., Trinconi, C. T., Yokoyama-Yasunaka, J. K. U., & Uliana, S. R. B. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002842 · Cited by 37
Prophylactic properties of a Leishmania‐specific hypothetical protein in a murine model of visceral leishmaniasis
Lage, D. P., Martins, V. T., Duarte, M. C., Garde, E., Chávez‐Fumagalli, M. Á., Menezes‐Souza, D., Roatt, B. M., Tavares, C. A. P., Soto, M., & Coelho, E. A. F. (2015) · Parasite Immunology · doi:10.1111/pim.12287 · Cited by 37
A narrative review of visceral leishmaniasis in Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, the Crimean Peninsula and Southern Russia
Strelkova, M. V., Ponirovsky, E. N., En, M., Николаевна, Ж. Е., Razakov, S. A., Kovalenko, D. A., Schnur, L. F., & Schönian, G. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0925-z · Cited by 37
Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient
Alves‐Ferreira, E. V. C., de Toledo, J. S., de Oliveira, A. H. C., Ferreira, T. R., Ruy, P. D. C., Pinzan, C. F., Santos, R. F., Boaventura, V. S., Rojo, D., López‐Gonzálvez, Á., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004018 · Cited by 38
Geographic Distribution of Leishmania Species in Ecuador Based on the Cytochrome B Gene Sequence Analysis
Kato, H., Gómez, E. A., Robles, L. M., Muzzio-Aroca, J., Velez, L. N., Calvopiña, M., Romero-Álvarez, D., Mimori, T., Uezato, H., & Hashiguchi, Y. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004844 · Cited by 37
Asymptomatic infection with American cutaneous leishmaniasis: epidemiological and immunological studies
Andrade-Narvaez, F. J., Loría‐Cervera, E. N., Sosa-Bibiano, E. I., & Wynsberghe, N. R. V. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160138 · Cited by 37
The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control
Figliuolo, V. R., Chaves, S. P., Savio, L. E. B., Thorstenberg, M. L., de Salles, É. M., Takiya, C. M., Lima, M. R. D., Guedes, H. L. D. M., Rossi‐Bergmann, B., & Coutinho‐Silva, R. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9544-1 · Cited by 37
DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis
Celes, F. S., Trovatti, E., Khouri, R., Weyenbergh, J. V., Ribeiro, S. J. L., Borges, V. M., Barud, H. D. S., & de Oliveira, C. I. (2016) · Scientific Reports · doi:10.1038/srep38330 · Cited by 37
Antileishmanial activities of caffeic acid phenethyl ester loaded PLGA nanoparticles against Leishmania infantum promastigotes and amastigotes in vitro
Abamor, E. Ş. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.12.006 · Cited by 38
Species-specific ecological niche modelling predicts different range contractions for Lutzomyia intermedia and a related vector of Leishmania braziliensis following climate change in South America
McIntyre, S. L., Rangel, E. F., Ready, P. D., & de Carvalho, B. M. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2093-9 · Cited by 39
Amphotericin B-loaded mannose modified poly( d , l -lactide-co-glycolide) polymeric nanoparticles for the treatment of visceral leishmaniasis: in vitro and in vivo approaches
Ghosh, S., Das, S., De, A. K., Kar, N., & Bera, T. (2017) · RSC Advances · doi:10.1039/c7ra04951j · Cited by 37
High-throughput sequencing of kDNA amplicons for the analysis ofLeishmaniaminicircles and identification of Neotropical species
Kocher, A., Valière, S., Bañuls, A., & Murienne, J. (2017) · Parasitology · doi:10.1017/s0031182017002013 · Cited by 37
Genetic diversity of Leishmania donovani that causes cutaneous leishmaniasis in Sri Lanka: a cross sectional study with regional comparisons
Kariyawasam, U., Selvapandiyan, A., Rai, K., Wani, T. H., Ahuja, K., Beg, M. A., Premathilake, H., Bhattarai, N. R., Siriwardana, Y. D., Zhong, D., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2883-x · Cited by 37
Chemical composition of Ocimum canum Sims. essential oil and the antimicrobial, antiprotozoal and ultrastructural alterations it induces in Leishmania amazonensis promastigotes
da Silva, V. D., Almeida-Souza, F., Teles, A. M., Azalim-Neto, P., Mondêgo‐Oliveira, R., Filho, N. E. M., Taniwaki, N. N., Abreu‐Silva, A. L., Calabrese, K. D. S., & Filho, V. E. M. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2018.04.005 · Cited by 37
Leishmania Infection Induces MicroRNA hsa-miR-346 in Human Cell Line-Derived Macrophages
Diotallevi, A., Santi, M. D., Buffi, G., Ceccarelli, M., Vitale, F., Galluzzi, L., & Magnani, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01019 · Cited by 37
Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number
Yasur-Landau, D., Jaffe, C. L., David, L., Doron‐Faigenboim, A., & Baneth, G. (2018) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2018.08.002 · Cited by 37
Geographical distribution of Leishmania species in Colombia, 1985-2017
Salgado‐Almario, J., Hernández, C. A., & Ovalle‐Bracho, C. (2019) · Biomédica · doi:10.7705/biomedica.v39i3.4312 · Cited by 37
Phenotypic and Functional Profiles of Antigen-Specific CD4+ and CD8+ T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis
Egui, A., Ledesma, D., Pérez-Antón, E., Montoya, A., Gómez, I., Robledo, S. M., Infante, J. J., Vélez, I. D., López, M. C., & Thomas, M. C. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00393 · Cited by 37
Nanoparticle-mediated magnetic hyperthermia is an effective method for killing the human-infective protozoan parasite Leishmania mexicana in vitro
Berry, S. L., Walker, K., Hoskins, C., Telling, N. D., & Price, H. P. (2019) · Scientific Reports · doi:10.1038/s41598-018-37670-9 · Cited by 37
Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite
Cabello‐Donayre, M., Orrego, L. M., Herráez, E., Vargas, P., Martínez‐García, M., Campos‐Salinas, J., Pérez‐Victoria, I., Vicente, B., Marı́n, J. J. G., & Pérez-Victoria, J. M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03258-3 · Cited by 35
TLR7 Sensing by Neutrophils Is Critical for the Control of Cutaneous Leishmaniasis
Regli, I. B., Passelli, K., Martínez-Salazar, B., Amore, J., Hurrell, B. P., Müller, A. J., & Tacchini‐Cottier, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107746 · Cited by 37
Chalcones identify cTXNPx as a potential antileishmanial drug target
Escrivani, D. O., Charlton, R. L., Caruso, M. B., Burle-Caldas, G. D. A., Borsodi, M. P. G., Zingali, R. B., Arruda-Costa, N., Palmeira-Mello, M. V., de Jesus, J. B., de Souza, A. M. T., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009951 · Cited by 38
Diagnosis of Cutaneous Leishmaniasis: Why Punch When You Can Scrape?
Saab, M., Hage, H. E., Charafeddine, K. M., Habib, R., & Khalifeh, I. M. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0512 · Cited by 37
A review on potential therapeutic targets for the treatment of leishmaniasis
Sheikh, S. Y., Hassan, F., Shukla, D., Bala, S., Faruqui, T., Akhter, Y., Khan, A. R., & Nasibullah, M. (2024) · Parasitology International · doi:10.1016/j.parint.2024.102863 · Cited by 36
Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony
Moreira, D. D. S., do Monte‐Neto, R. L., Andrade, J. M., Santi, A. M. M., dos Reis, P. G., Frézard, F., & Murta, S. M. F. (2013) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2013.08.001 · Cited by 36
Identification of the molecular attributes required for aminoglycoside activity against Leishmania
Shalev, M., Kondo, J., Kopelyanskiy, D., Jaffe, C., Adir, N., & Baasov, T. (2013) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1307365110 · Cited by 34
Multilocus microsatellite typing reveals a genetic relationship but, also, genetic differences between Indian strains of Leishmania tropica causing cutaneous leishmaniasis and those causing visceral leishmaniasis
Krayter, L., Bumb, R. A., Azmi, K., Wuttke, J., Malik, M. D., Schnur, L. F., Salotra, P., & Schönian, G. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-123 · Cited by 36
A Novel Molecular Test to Diagnose Canine Visceral Leishmaniasis at the Point of Care
Castellanos-González, A., Saldarriaga, Ó. A., Tartaglino, L. C., Gacek, R., Temple, E., Sparks, H., Melby, P. C., & Travi, B. L. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0145 · Cited by 36
Oleanolic acid (OA) as an antileishmanial agent: Biological evaluation and in silico mechanistic insights
Melo, T. S., Gattass, C. R., Soares, D. C., Cunha, M. R., Ferreira, C., Tavares, M. T., Saraiva, E. M., Parise‐Filho, R., Braden, H., & Delorenzi, J. C. M. O. B. (2016) · Parasitology International · doi:10.1016/j.parint.2016.01.001 · Cited by 36
Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity
Marr, A. K., Cen, S., Hancock, R. E. W., & McMaster, W. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-15 · Cited by 36
A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis
Lage, D. P., Martins, V. T., Duarte, M. C., Costa, L. E., Garde, E., Dimer, L. M., Kursancew, A. C. S., Chávez‐Fumagalli, M. Á., de Magalhães-Soares, D. F., Menezes‐Souza, D., et al. (2016) · Parasitology Research · doi:10.1007/s00436-016-4904-x · Cited by 36
Epidemiology of human leishmaniasis in Greece, 1981-2011
Gkolfinopoulou, K., Bitsolas, N., Patrinos, S., Veneti, L., Marka, A., Δουγάς, Γ., Pervanidou, D., Detsis, M., Triantafillou, E., Georgakopoulou, T., et al. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.28.20532 · Cited by 36
Vectorborne Transmission ofLeishmania infantumfrom Hounds, United States
Schaut, R. G., Robles‐Murguia, M., Juelsgaard, R., Esch, K. J., Bartholomay, L. C., Ramalho-Ortigão, M., & Petersen, C. A. (2015) · Emerging infectious diseases · doi:10.3201/eid2112.141167 · Cited by 36
Demographic and spatio-temporal distribution of cutaneous leishmaniasis in the Souf oasis (Eastern South of Algeria): Results of 13 years
Khezzani, B., & Bouchemal, S. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.11.012 · Cited by 36
A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
Alves-Silva, M. V., Nico, D., Morrot, A., Palatnik, M., & Palatnik, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00100 · Cited by 36
Prevalence of Leishmania species in rodents: A systematic review and meta-analysis in Iran
Foroutan, M., Khademvatan, S., Majidiani, H., Khalkhali, H. R., Hedayati-Rad, F., Khashaveh, S., & Mohammadzadeh, H. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.04.022 · Cited by 36
Diversity and altitudinal distribution of phlebotomine sand flies (Diptera: Psychodidae) in visceral leishmaniasis endemic areas of northwest Ethiopia
Yared, S., Gebresilassie, A., Akililu, E., Deribe, K., Balkew, M., Warburg, A., Hailu, A., & Gebre-Michael, T. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.07.008 · Cited by 36
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study
Dorlo, T. P. C., Kip, A. E., Younis, B. M., Ellis, S., Alves, F. P., Beijnen, J. H., Njenga, S., Kirigi, G., Hailu, A., Olobo, J. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx283 · Cited by 36
Human Competence to Transmit Leishmania infantum to Lutzomyia longipalpis and the Influence of Human Immunodeficiency Virus Infection
Ferreira, G. R., Ribeiro, J. C. C. B., Filho, A. M., Pereira, T. D. J. C. F., Parente, D. M., Pereira, H. F., da Silva, J. C., Zacarias, D. A., da Silva, L. V., Faustino, S. K. M., et al. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0883 · Cited by 36
Geospatial-temporal distribution of Tegumentary Leishmaniasis in Colombia (2007–2016)
Herrera, G., Teherán, A. A., Pradilla, I. F., Vera, M. J., & Ramírez, J. D. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006419 · Cited by 36
UnderstandingLeishmaniaparasites through proteomics and implications for the clinic
Sundar, S., & Singh, B. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1468754 · Cited by 35
Composition of sand fly fauna (Diptera: Psychodidae) and detection of Leishmania DNA (Kinetoplastida: Trypanosomatidae) in different ecotopes from a rural settlement in the central Amazon, Brazil
Chagas, É. C. D. S., da Silva, A. S., Fé, N. F., Ferreira, L. S., Sampaio, V. D. S., Terrazas, W. C. M., Guerra, J. A. D. O., Souza, R. A. F. D., Silveira, H., & Guerra, M. D. G. V. B. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2743-6 · Cited by 36
Clinical and diagnostic aspects of feline cutaneous leishmaniosis in Venezuela
Rivas, A. K., Alcover, M. M., Martínez-Orellana, P., Montserrat‐Sangrà, S., Nachum‐Biala, Y., Bardagí, M., Fisa, R., Riera, C., Baneth, G., & Solano‐Gallego, L. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2747-2 · Cited by 36
Extracellular release of virulence factor major surface protease via exosomes in Leishmania infantum promastigotes
Marshall, S., Kelly, P. H., Singh, B. K., Pope, R. M., Kim, P. H., Zhanbolat, B., Wilson, M. E., & Yao, C. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2937-y · Cited by 39
Purinergic Cooperation Between P2Y2 and P2X7 Receptors Promote Cutaneous Leishmaniasis Control: Involvement of Pannexin-1 and Leukotrienes
Thorstenberg, M. L., Ferreira, M. V. R., Amorim, N., Canetti, C. D. A., Morrone, F. B., Filho, J. C. F. A., & Coutinho‐Silva, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01531 · Cited by 36
2-Aryl-quinazolin-4(3H)-ones as an inhibitor of leishmania folate pathway: In vitro biological evaluation, mechanism studies and molecular docking
Romero, A. H., Rodríguez, N., & Oviedo, H. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.10.028 · Cited by 36
Insecticide–impregnated dog collars reduce infantile clinical visceral leishmaniasis under operational conditions in NW Iran: A community–wide cluster randomised trial
Courtenay, O., Bazmani, A., Parvizi, P., Ready, P. D., & Cameron, M. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007193 · Cited by 36
Leishmania donovani 90 kD Heat Shock Protein – Impact of Phosphosites on Parasite Fitness, Infectivity and Casein Kinase Affinity
Hombach, A., Bartsch, K., Smirlis, D., Rosenqvist, H., MacDonald, A., Dingli, F., Loew, D., Späth, G. F., Rachidi, N., Wiese, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41640-0 · Cited by 34
TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection
Sauter, I. P., Sotomayor, K. G. M., de Assis, J. B., Sá‐Nunes, A., Torrecilhas, A. C., Staquicini, D. I., Pasqualini, R., Arap, W., & Cortéz, M. (2019) · JCI Insight · doi:10.1172/jci.insight.126207 · Cited by 36
Envisioning the Innovations in Nanomedicine to Combat Visceral Leishmaniasis: For Future Theranostic Application
Singh, O. P., Gedda, M. R., Mudavath, S. L., Srivastava, O. N., & Sundar, S. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0448 · Cited by 36
Global status of synchronizing Leishmania RNA virus in Leishmania parasites: A systematic review with meta‐analysis
Saberi, R., Fakhar, M., Mohebali, M., Anvari, D., & Gholami, S. (2019) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13316 · Cited by 36
Infection of the equine population by Leishmania parasites
Mhadhbi, M., & Sassi, A. (2019) · Equine Veterinary Journal · doi:10.1111/evj.13178 · Cited by 36
Biogenic Metal Nanoparticles as A Potential Class of Antileishmanial Agents: Mechanisms and Molecular Targets
Ahmad, A., Ullah, S., Syed, F., Tahir, K., Khan, A. U., & Yuan, Q. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0413 · Cited by 39
Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia
van Henten, S., Tesfaye, A. B., Abdela, S. G., Zewdu, F. T., Fikre, H., Buyze, J., Kassa, M., Cnops, L., Pareyn, M., Mohammed, R., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009460 · Cited by 36
Seroprevalence and Risk Factors Associated with Canine Leishmaniasis in Egypt
Selim, A., Shoulah, S., Abdelhady, A., Alouffi, A., Alraey, Y., & Al-Salem, W. S. (2021) · Veterinary Sciences · doi:10.3390/vetsci8100236 · Cited by 37
Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients
Guéry, R., Walker, S. L., Harms, G., Neumayr, A. L. C., van Thiel, P. P. A. M., Gangneux, J., Clerinx, J., Söbirk, S. K., Visser, L. G., Lachaud, L., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009863 · Cited by 36
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
Mohan, S., Revill, P. A., Malvolti, S., Malhame, M., Sculpher, M. J., & Kaye, P. M. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010471 · Cited by 36
Epidemiology of Visceral Leishmaniasis in Algeria: An Update
Adel, A., Boughoufalah, A., Saegerman, C., Deken, R. D., Bouchene, Z., Soukehal, A., Berkvens, D. L., & Boelaert, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099207 · Cited by 36
Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece
Georgiadou, S. P., Stefos, A., Spanakos, G. K., Skrimpas, S., Makaritsis, K. P., Sipsas, N. V., & Dalekos, G. Ν. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.02.021 · Cited by 36
Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
van Griensven, J., Zijlstra, E. E., & Hailu, A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003023 · Cited by 36
Leishmania infantum Amastigotes Trigger a Subpopulation of Human B Cells with an Immunoregulatory Phenotype
Andreani, G., Ouellet, M., Menasria, R., Gómez, A., Barat, C., & Tremblay, M. J. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003543 · Cited by 36
Different secreted phosphatase activities inLeishmania amazonensis
Fernandes, A. C. S., Soares, D. C., Saraiva, E. M., Meyer‐Fernandes, J. R., & Souto-Padrón, T. C. B. S. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12080 · Cited by 36
Visceral Leishmaniasis Outbreak in South Sudan 2009–2012: Epidemiological Assessment and Impact of a Multisectoral Response
Abubakar, A., Ruiz-Postigo, J. A., Pita, J., Lado, M., Ben-Ismail, R., Argaw, D., & Alvar, J. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002720 · Cited by 36
Detection of Leishmania-specific DNA and surface antigens using a combination of functionalized magnetic beads and cadmium selenite quantum dots
Ανδρεάδου, Μ., Liandris, E., Gazouli, M., Ματαράγκα, Α., Tachtsidis, I., Goutas, N., Vlachodimitropoulos, D. G., & Ikonomopoulos, J. (2015) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2015.11.019 · Cited by 36
Gold‐NHC complexes as potent bioactive compounds
Al‐Majid, A. M., Sammer Yousuf, B., Choudhary, M. I., Nahra, F., & Nolan, S. P. (2016) · ChemistrySelect · doi:10.1002/slct.201600009 · Cited by 36
Detection of Leishmania spp. in Bats from an Area of Brazil Endemic for Visceral Leishmaniasis
de Rezende, M. B., Herrera, H. M., Carvalho, C. M. E., dos Anjos, E. A. C., Ramos, C. A. D. N., Araújo, F. R., Torres, J. M., & de Oliveira, C. E. (2017) · Transboundary and Emerging Diseases · doi:10.1111/tbed.12597 · Cited by 36
The mass use of deltamethrin collars to control and prevent canine visceral leishmaniasis: A field effectiveness study in a highly endemic area
Leite, B. M. M., Solcà, M. D. S., Santos, L. C. S., Coelho, L. B., Amorim, L. D. A. F., Donato, L. E., Passos, S. M. D. S., de Almeida, A. O., Veras, P. S. T., & Fraga, D. B. M. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006496 · Cited by 36
SisLeish: A multi-country standardized information system to monitor the status of Leishmaniasis in the Americas
Maia‐Elkhoury, A. N. S., Valadas, S. Y. O. B., Buzanovsky, L. P., Rocha, F., & Sanchez-Vazquez, M. J. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005868 · Cited by 35
G-Quadruplex DNAzyme-Substrated CRISPR/Cas12 Assay for Label-Free Detection of Single-Celled Parasitic Infection
Gao, H., Feng, M., Li, F., Zhang, K., Zhang, T., Zhang, Z., Yang, C.-Y., Deng, R., Zhang, J., & Jiang, P. (2022) · ACS Sensors · doi:10.1021/acssensors.2c01104 · Cited by 35
Phosphoproteomic analysis of wild‐type and antimony‐resistant Leishmania braziliensis lines by 2D‐DIGE technology
Moreira, D. D. S., Pescher, P., Laurent‐Winter, C., Lenormand, P., Späth, G. F., & Murta, S. M. F. (2015) · PROTEOMICS · doi:10.1002/pmic.201400611 · Cited by 35
Leishmania tropica in Stray Dogs in Southeast Iran.
Bamorovat, M., Sharifi, I., Dabiri, S., Mohammadi, M. A., Harandi, M. F., Mohebali, M., Aflatoonian, M. R., & Keyhani, A. (2015) · Europe PMC (PubMed Central) · Cited by 35
Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis
Bhattacharyya, T., Bowes, D. E., EL-Safi, S. H., Sundar, S., Falconar, A. K. I., Singh, O. P., Kumar, R., Ahmed, O., Boelaert, M., & Miles, M. A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002675 · Cited by 35
Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population
Testasicca, M. C. D. S., dos Santos, M. S., Machado, L. F. M., Serufo, Â. V., Doro, D., de Avelar, D. M., Tibúrcio, A. M. L., Abrantes, C. D. F., Machado-Coelho, G. L. L., Grimaldi, G., et al. (2014) · Veterinary Parasitology · doi:10.1016/j.vetpar.2014.04.025 · Cited by 35
Community knowledge, attitude and practice towards cutaneous leishmaniasis endemic area Ochello, Gamo Gofa Zone, South Ethiopia
Kebede, N., Worku, A., Ali, A., Animut, A., Negash, Y., Gebreyes, W. A., & Satoskar, A. R. (2016) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2016.01.018 · Cited by 35
Spatial modeling of cutaneous leishmaniasis in the Andean region of Colombia
Flórez, M. P., Ocampo, C. B., Valderrama‐Ardila, C., & Alexander, N. D. E. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160074 · Cited by 35
Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis
Bhattacharya, P., Dey, R., Dagur, P. K., Joshi, A. B., Ismail, N., Gannavaram, S., Debrabant, A., Akue, A. D., KuKuruga, M. A., Selvapandiyan, A., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004963 · Cited by 34

Authors: Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
Affiliations: World Health Organization (CH)
Universidad de Antioquia (CO)
Centers for Disease Control and Prevention (US)
Instituto de Salud Carlos III (ES)
Corresponding author: Alvar, Jorge
ORCID: Alvar, Jorge
Vélez, Iván D.
Bern, Caryn
Cano, Jorge
Boer, Margriet den
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2012-05-31
Volume: 7
Issue: 5
Pages: e35671
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0035671
PMC: PMC3365071
OpenAlex: W2107915297
Cited by: 5,141
References: 51
Citations by year: 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
FWCI: 310.03
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, public-domain)
Europe PMC (PubMed Central) (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
Funders: Sanofi
Universidad de Medellín
Pan American Health Organization
Agencia Española de Cooperación Internacional para el Desarrollo
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
Keywords: leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
MeSH terms: Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks